Literature DB >> 7978973

Cancer mortality in chrysotile mining and milling: exposure-response.

D Liddell.   

Abstract

New material was presented from pending publications arising from the follow-up to 1988 of the Quebec cohort of over 10,000 chrysotile miners and millers born 1891-1920. In reviewing these and previous findings, the following conclusions were drawn; they are supported, insofar as this is possible, by the only other relevant information, that from Balangero, in Northern Italy. There is strong evidence that the risk of lung cancer as a result of exposure to chrysotile at concentrations of less than 15 million particles per cubic foot is vanishingly small. At higher concentrations, the relative risk of lung cancer is elevated, but less so in smokers of 20 or more cigarettes a day than in others. The magnitude of this risk cannot be evaluated with any certainty, but this is unimportant as these higher concentrations (above about 50 f ml-1) are well outside the range of experience nowadays. There is no evidence that the risk of laryngeal cancer or of stomach cancer are adversely affected by exposure to chrysotile. Nor is there evidence of increased risks of other abdominal malignancies or of kidney cancer among chrysotile miners and millers. The risk of mesothelioma in chrysotile miners and millers is very low compared with the risks in populations exposed to amphiboles or to mixtures of fibres including even small proportions of amphiboles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7978973     DOI: 10.1093/annhyg/38.4.519

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  2 in total

1.  Mortality in a Chinese chrysotile miner cohort.

Authors:  Xiaorong Wang; Sihao Lin; Eiji Yano; Hong Qiu; Igtanius T S Yu; Lapah Tse; Yajia Lan; Mianzhen Wang
Journal:  Int Arch Occup Environ Health       Date:  2011-07-28       Impact factor: 3.015

2.  Cancer mortality in Chinese chrysotile asbestos miners: exposure-response relationships.

Authors:  Xiaorong Wang; Eiji Yano; Sihao Lin; Ignatius T S Yu; Yajia Lan; Lap Ah Tse; Hong Qiu; David C Christiani
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.